Freehamlet Medical Limited 10171314 false 2023-06-01 2024-05-31 2024-05-31 The principal activity of the company is general medical practice activities. Digita Accounts Production Advanced 6.30.9574.0 true true 10171314 2023-06-01 2024-05-31 10171314 2024-05-31 10171314 core:RetainedEarningsAccumulatedLosses 2024-05-31 10171314 core:CurrentFinancialInstruments 2024-05-31 10171314 core:CurrentFinancialInstruments core:WithinOneYear 2024-05-31 10171314 bus:SmallEntities 2023-06-01 2024-05-31 10171314 bus:AuditExemptWithAccountantsReport 2023-06-01 2024-05-31 10171314 bus:FullAccounts 2023-06-01 2024-05-31 10171314 bus:SmallCompaniesRegimeForAccounts 2023-06-01 2024-05-31 10171314 bus:RegisteredOffice 2023-06-01 2024-05-31 10171314 bus:Director1 2023-06-01 2024-05-31 10171314 bus:Director2 2023-06-01 2024-05-31 10171314 bus:PrivateLimitedCompanyLtd 2023-06-01 2024-05-31 10171314 core:PlantMachinery 2023-06-01 2024-05-31 10171314 countries:EnglandWales 2023-06-01 2024-05-31 10171314 2023-05-31 10171314 2022-06-01 2023-05-31 10171314 2023-05-31 10171314 core:RetainedEarningsAccumulatedLosses 2023-05-31 10171314 core:CurrentFinancialInstruments 2023-05-31 10171314 core:CurrentFinancialInstruments core:WithinOneYear 2023-05-31 iso4217:GBP xbrli:pure

Registration number: 10171314

Freehamlet Medical Limited

Annual Report and Unaudited Filleted Abridged Financial Statements

for the Year Ended 31 May 2024

 

Freehamlet Medical Limited

Contents

Abridged Balance Sheet

1

Notes to the Unaudited Abridged Financial Statements

2 to 4

 

Freehamlet Medical Limited

(Registration number: 10171314)
Abridged Balance Sheet as at 31 May 2024

Note

2024
£

2023
£

Fixed assets

 

Tangible assets

4

1,330

909

Current assets

 

Debtors

-

7,735

Investments

5

1,106

1,106

Cash at bank and in hand

 

368,854

288,985

 

369,960

297,826

Creditors: Amounts falling due within one year

(25,916)

(25,830)

Net current assets

 

344,044

271,996

Net assets

 

345,374

272,905

Capital and reserves

 

Profit and loss account

345,374

272,905

Total equity

 

345,374

272,905

For the financial year ending 31 May 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Profit and Loss Account has been taken.

All of the company’s members have consented to the preparation of an Abridged Profit and Loss Account and an Abridged Balance Sheet in accordance with Section 444(2A) of the Companies Act 2006.

Approved and authorised by the Board on 14 February 2025 and signed on its behalf by:
 

Dr J E Cooper

Director

Dr G C Werrett

Director

 

Freehamlet Medical Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 May 2024

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Calyx House
South Road
Taunton
Somerset
TA1 3DU

These financial statements were authorised for issue by the Board on 14 February 2025.

2

Accounting policies

Statement of compliance

These abridged financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These abridged financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern

The financial statements have been prepared on a going concern basis.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

 

Freehamlet Medical Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 May 2024

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Plant and Machinery

20% straight line

Investments

Investments in equity shares which are publicly traded or where the fair value can be measured reliably are initially measured at fair value, with changes in fair value recognised in profit or loss. Investments in equity shares which are not publicly traded and where fair value cannot be measured reliably are measured at cost less impairment.


Interest income on debt securities, where applicable, is recognised in income using the effective interest method. Dividends on equity securities are recognised in income when receivable.

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 2 (2023 - 2).

 

Freehamlet Medical Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 May 2024

4

Tangible assets

Total
£

Cost or valuation

At 1 June 2023

3,286

Additions

632

At 31 May 2024

3,918

Depreciation

At 1 June 2023

2,377

Charge for the year

211

At 31 May 2024

2,588

Carrying amount

At 31 May 2024

1,330

At 31 May 2023

909

5

Current asset investments

2024
£

2023
£

Investment in Plymouth Anaesthesia LLP

1,106

1,106